Ipsen
Boulogne-billancourt · Founded 1929
About Ipsen
Ipsen is a global specialty-driven biopharmaceutical company focused on innovation and specialty care. Ipsen develops and commercializes innovative medicines in three key therapeutic areas: oncology, neuroscience, and rare disease. Its dedication to oncology is exemplified by its expanding portfolio of key therapies for prostate cancer, neuroendocrine tumors, renal cell carcinoma and pancreatic cancer.
Company Facts
- Founded: 1929
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 1,001 – 5,000
- Estimated revenue: $1M – $10M
- Total funding: $574.7M
- Funding stage: IPO
- Last round: Post-IPO Debt (Mar 2025)
- Ticker: epa:IPN
- Website: ipsen.com
- Phone: (331) 583-3500
Industries & Categories
Biotechnology, Pharmaceutical, Product Research
Social Profiles
Canonical: https://fsome.com/organization/ipsen-28654 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.